KELLI FLETCHER: Open Payments
NPI 1811483407 · GRAPEVINE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$923 in 40 payments from 16 companies in 2025. Trend: 2023 $950 · 2024 $784 · 2025 $923
Food & beverage: $923
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 9 | $161 |
| PFIZER INC. | 6 | $158 |
| Dendreon Pharmaceuticals LLC | 4 | $134 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $100 |
| Ferring Pharmaceuticals Inc. | 3 | $84 |
| Antares Pharma, Inc. | 4 | $69 |
| Olympus America Inc. | 1 | $48 |
| Teleflex LLC | 1 | $28 |
| Janssen Biotech, Inc. | 1 | $22 |
| Procept Biorobotics Corporation | 1 | $20 |
Products named: XTANDI, PROVENGE, ORGOVYX, Nubeqa, ADSTILADRIN, XYOSTED, GEMTESA, iTIND System.
Industry payments across TX — which companies pay providers there.
